Robuta

https://pubmed.ncbi.nlm.nih.gov/8391072/
These pharmacological differences suggest that angiotensin II receptor antagonists and ACE inhibitors may not be therapeutically equivalent.
clinical pharmacologyangiotensinbradykininhumanforearm
https://pubmed.ncbi.nlm.nih.gov/18084312/?dopt=Abstract
effectbradykininmetabolisminhibitorsevoked
https://elifesciences.org/articles/59177?utm_source=Unknown+List&utm_campaign=7a5785d58d-EMAIL_CAMPAIGN_2020_07_27_02_37&utm_medium=email&utm_term=0_-7a5785d58d-
Gene expression analysis reveals a novel, integrated molecular mechanism for much of the pathogenesis of COVID-19 that provides therapeutic intervention points...
mechanisticmodeltherapeuticinterventionscovid